SLC19A1 Gene

HGNC Family Solute carriers (SLC), Minor histocompatibility antigens
Name solute carrier family 19 (folate transporter), member 1
Description The membrane protein encoded by this gene is a transporter of folate and is involved in the regulation of intracellular concentrations of folate. Three transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Mar 2011]
Summary
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nSLC19A1, which encodes the reduced folate carrier (RFC1), is a ubiquitously expressed membrane transporter essential for the cellular uptake of folate cofactors and antifolate agents. This carrier maintains intracellular folate homeostasis and, in doing so, supports one‐carbon metabolic processes vital for DNA synthesis, repair, and methylation. Detailed transcriptional studies have revealed multiple promoter regions and isoforms of the SLC19A1 transcript that underscore its pivotal role in folate metabolism and drug transport."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "8"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nA wealth of clinical investigations has demonstrated that genetic polymorphisms in SLC19A1—most notably the common G80A (H27R) variant—can significantly influence the efficacy and toxicity of antifolate therapies such as methotrexate. Altered RFC1 function modulates drug uptake and polyglutamation, thereby affecting treatment outcomes in conditions including acute lymphoblastic leukemia, rheumatoid arthritis, and psoriasis. Moreover, maternal variants in SLC19A1 have been linked to developmental anomalies such as neural tube defects, spina bifida, and autism, likely via impaired folate transport leading to decreased methylation capacity. Collectively, these findings support the use of SLC19A1 genotype as a potential predictive biomarker for both therapeutic response and disease susceptibility."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "9", "end_ref": "40"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nRecent mechanistic studies have further expanded the known repertoire of SLC19A1 functions. In addition to its canonical role in folate and antifolate transport, SLC19A1 has been identified as the principal importer of cyclic dinucleotides such as 2′3′-cGAMP—a discovery that links folate transport with innate immune activation and antitumor responses. Molecular analyses in leukemic cell models have revealed clustering of mutations within specific transmembrane domains of RFC1 that can confer resistance to antifolate agents. These insights into SLC19A1’s structure–function relationships and its emerging role in immune signaling highlight novel avenues for therapeutic intervention in oncology and immunotherapy."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "41", "end_ref": "48"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "J R Whetstine, A J Gifford, T Witt, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Single nucleotide polymorphisms in the human reduced folate carrier: characterization of a high-frequency G/A variant at position 80 and transport properties of the His(27) and Arg(27) carriers."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Cancer Res (2001)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "11705857"}], "href": "https://pubmed.ncbi.nlm.nih.gov/11705857"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Johnathan R Whetstine, Robin M Flatley, Larry H Matherly "}, {"type": "b", "children": [{"type": "t", "text": "The human reduced folate carrier gene is ubiquitously and differentially expressed in normal human tissues: identification of seven non-coding exons and characterization of a novel promoter."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem J (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1042/BJ20020512"}], "href": "https://doi.org/10.1042/BJ20020512"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12144527"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12144527"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Caroline Laverdière, Sonia Chiasson, Irina Costea, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Polymorphism G80A in the reduced folate carrier gene and its relationship to methotrexate plasma levels and outcome of childhood acute lymphoblastic leukemia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Blood (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1182/blood.V100.10.3832"}], "href": "https://doi.org/10.1182/blood.V100.10.3832"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12411325"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12411325"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Patrizia De Marco, Maria Grazia Calevo, Anna Moroni, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Reduced folate carrier polymorphism (80A-->G) and neural tube defects."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur J Hum Genet (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/sj.ejhg.5200946"}], "href": "https://doi.org/10.1038/sj.ejhg.5200946"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12673279"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12673279"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Isabelle Morin, Angela M Devlin, Daniel Leclerc, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Evaluation of genetic variants in the reduced folate carrier and in glutamate carboxypeptidase II for spina bifida risk."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Genet Metab (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/s1096-7192(03)00086-6"}], "href": "https://doi.org/10.1016/s1096-7192(03"}, {"type": "t", "text": "00086-6) PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12855225"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12855225"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Larry H Matherly, Zhanjun Hou, Yijun Deng "}, {"type": "b", "children": [{"type": "t", "text": "Human reduced folate carrier: translation of basic biology to cancer etiology and therapy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Metastasis Rev (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s10555-007-9046-2"}], "href": "https://doi.org/10.1007/s10555-007-9046-2"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17334909"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17334909"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Larry H Matherly, Mike R Wilson, Zhanjun Hou "}, {"type": "b", "children": [{"type": "t", "text": "The major facilitative folate transporters solute carrier 19A1 and solute carrier 46A1: biology and role in antifolate chemotherapy of cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Drug Metab Dispos (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1124/dmd.113.055723"}], "href": "https://doi.org/10.1124/dmd.113.055723"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24396145"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24396145"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Christopher Ritchie, Anthony F Cordova, Gaelen T Hess, et al. "}, {"type": "b", "children": [{"type": "t", "text": "SLC19A1 Is an Importer of the Immunotransmitter cGAMP."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.molcel.2019.05.006"}], "href": "https://doi.org/10.1016/j.molcel.2019.05.006"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31126740"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31126740"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Gary M Shaw, Edward J Lammer, Huiping Zhu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Maternal periconceptional vitamin use, genetic variation of infant reduced folate carrier (A80G), and risk of spina bifida."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Med Genet (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/ajmg.10195"}], "href": "https://doi.org/10.1002/ajmg.10195"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "11857541"}], "href": "https://pubmed.ncbi.nlm.nih.gov/11857541"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Caroline L Relton, Craig S Wilding, Alison J Laffling, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Low erythrocyte folate status and polymorphic variation in folate-related genes are associated with risk of neural tube defect pregnancy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Genet Metab (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ymgme.2003.12.010"}], "href": "https://doi.org/10.1016/j.ymgme.2003.12.010"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15059614"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15059614"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "C L Relton, C S Wilding, M S Pearce, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Gene-gene interaction in folate-related genes and risk of neural tube defects in a UK population."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Med Genet (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1136/jmg.2003.010694"}], "href": "https://doi.org/10.1136/jmg.2003.010694"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15060097"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15060097"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Christine F Skibola, Matthew S Forrest, Fabio Coppedé, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Polymorphisms and haplotypes in folate-metabolizing genes and risk of non-Hodgkin lymphoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Blood (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1182/blood-2004-02-0557"}], "href": "https://doi.org/10.1182/blood-2004-02-0557"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15198953"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15198953"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Thierry Dervieux, Joel Kremer, Diana Orentas Lein, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Contribution of common polymorphisms in reduced folate carrier and gamma-glutamylhydrolase to methotrexate polyglutamate levels in patients with rheumatoid arthritis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pharmacogenetics (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/00008571-200411000-00004"}], "href": "https://doi.org/10.1097/00008571-200411000-00004"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15564880"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15564880"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "T Dervieux, D Furst, D O Lein, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Pharmacogenetic and metabolite measurements are associated with clinical status in patients with rheumatoid arthritis treated with methotrexate: results of a multicentred cross sectional observational study."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Ann Rheum Dis (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1136/ard.2004.033399"}], "href": "https://doi.org/10.1136/ard.2004.033399"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15677700"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15677700"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Robert de Jonge, Jan Hendrik Hooijberg, Bertrand D van Zelst, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Effect of polymorphisms in folate-related genes on in vitro methotrexate sensitivity in pediatric acute lymphoblastic leukemia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Blood (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1182/blood-2004-12-4941"}], "href": "https://doi.org/10.1182/blood-2004-12-4941"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15797993"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15797993"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Tracy J Lightfoot, Christine F Skibola, Eleanor V Willett, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Risk of non-Hodgkin lymphoma associated with polymorphisms in folate-metabolizing genes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Epidemiol Biomarkers Prev (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1055-9965.EPI-05-0515"}], "href": "https://doi.org/10.1158/1055-9965.EPI-05-0515"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16365025"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16365025"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Fabio Coppedè, Giulia Marini, Stefania Bargagna, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Folate gene polymorphisms and the risk of Down syndrome pregnancies in young Italian women."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Med Genet A (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/ajmg.a.31217"}], "href": "https://doi.org/10.1002/ajmg.a.31217"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16596679"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16596679"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "A Mostowska, K K Hozyasz, P P Jagodzinski "}, {"type": "b", "children": [{"type": "t", "text": "Maternal MTR genotype contributes to the risk of non-syndromic cleft lip and palate in the Polish population."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Genet (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/j.1399-0004.2006.00618.x"}], "href": "https://doi.org/10.1111/j.1399-0004.2006.00618.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16712703"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16712703"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Iris Scala, Barbara Granese, Maria Sellitto, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Analysis of seven maternal polymorphisms of genes involved in homocysteine/folate metabolism and risk of Down syndrome offspring."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Genet Med (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/01.gim.0000228206.21793.82"}], "href": "https://doi.org/10.1097/01.gim.0000228206.21793.82"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16845273"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16845273"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "S Jill James, Stepan Melnyk, Stefanie Jernigan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Metabolic endophenotype and related genotypes are associated with oxidative stress in children with autism."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Med Genet B Neuropsychiatr Genet (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/ajmg.b.30366"}], "href": "https://doi.org/10.1002/ajmg.b.30366"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16917939"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16917939"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Abee L Boyles, Ashley V Billups, Kristen L Deak, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Neural tube defects and folate pathway genes: family-based association tests of gene-gene and gene-environment interactions."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Environ Health Perspect (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1289/ehp.9166"}], "href": "https://doi.org/10.1289/ehp.9166"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17035141"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17035141"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Hiroyuki Imanishi, Noboru Okamura, Mariko Yagi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genetic polymorphisms associated with adverse events and elimination of methotrexate in childhood acute lymphoblastic leukemia and malignant lymphoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Hum Genet (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s10038-006-0096-z"}], "href": "https://doi.org/10.1007/s10038-006-0096-z"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17180579"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17180579"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "R Takatori, K A Takahashi, D Tokunaga, et al. "}, {"type": "b", "children": [{"type": "t", "text": "ABCB1 C3435T polymorphism influences methotrexate sensitivity in rheumatoid arthritis patients."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Exp Rheumatol (2006)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17181924"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17181924"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Shinji Kishi, Cheng Cheng, Deborah French, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Ancestry and pharmacogenetics of antileukemic drug toxicity."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Blood (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1182/blood-2006-10-054528"}], "href": "https://doi.org/10.1182/blood-2006-10-054528"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17264302"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17264302"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Emanuela Campalani, Monica Arenas, Anthony M Marinaki, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Polymorphisms in folate, pyrimidine, and purine metabolism are associated with efficacy and toxicity of methotrexate in psoriasis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Invest Dermatol (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/sj.jid.5700808"}], "href": "https://doi.org/10.1038/sj.jid.5700808"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17410198"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17410198"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Ase Fredriksen, Klaus Meyer, Per Magne Ueland, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Large-scale population-based metabolic phenotyping of thirteen genetic polymorphisms related to one-carbon metabolism."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hum Mutat (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/humu.20522"}], "href": "https://doi.org/10.1002/humu.20522"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17436311"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17436311"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Karen Curtin, Martha L Slattery, Cornelia M Ulrich, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genetic polymorphisms in one-carbon metabolism: associations with CpG island methylator phenotype (CIMP) in colon cancer and the modifying effects of diet."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Carcinogenesis (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/carcin/bgm089"}], "href": "https://doi.org/10.1093/carcin/bgm089"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17449906"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17449906"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Petra Bohanec Grabar, Dusan Logar, Boris Lestan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genetic determinants of methotrexate toxicity in rheumatoid arthritis patients: a study of polymorphisms affecting methotrexate transport and folate metabolism."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur J Clin Pharmacol (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00228-008-0521-7"}], "href": "https://doi.org/10.1007/s00228-008-0521-7"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18607581"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18607581"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Robert de Jonge, Wim J E Tissing, Jan Hendrik Hooijberg, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Polymorphisms in folate-related genes and risk of pediatric acute lymphoblastic leukemia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Blood (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1182/blood-2008-07-165928"}], "href": "https://doi.org/10.1182/blood-2008-07-165928"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19020309"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19020309"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Egbert F Smit, Sjaak A Burgers, Bonne Biesma, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Randomized phase II and pharmacogenetic study of pemetrexed compared with pemetrexed plus carboplatin in pretreated patients with advanced non-small-cell lung cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Oncol (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1200/JCO.2008.19.1650"}], "href": "https://doi.org/10.1200/JCO.2008.19.1650"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19307503"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19307503"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Gary M Shaw, Wei Lu, Huiping Zhu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "118 SNPs of folate-related genes and risks of spina bifida and conotruncal heart defects."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "BMC Med Genet (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/1471-2350-10-49"}], "href": "https://doi.org/10.1186/1471-2350-10-49"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19493349"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19493349"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "Simon M Collin, Chris Metcalfe, Luisa Zuccolo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Association of folate-pathway gene polymorphisms with the risk of prostate cancer: a population-based nested case-control study, systematic review, and meta-analysis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Epidemiol Biomarkers Prev (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1055-9965.EPI-09-0223"}], "href": "https://doi.org/10.1158/1055-9965.EPI-09-0223"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19706844"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19706844"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "Alex A Adjei, Sumithra J Mandrekar, Grace K Dy, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Phase II trial of pemetrexed plus bevacizumab for second-line therapy of patients with advanced non-small-cell lung cancer: NCCTG and SWOG study N0426."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Oncol (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1200/JCO.2009.23.6406"}], "href": "https://doi.org/10.1200/JCO.2009.23.6406"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19841321"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19841321"}]}, {"type": "r", "ref": 34, "children": [{"type": "t", "text": "N Solanky, A Requena Jimenez, S W D'Souza, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Expression of folate transporters in human placenta and implications for homocysteine metabolism."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Placenta (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.placenta.2009.11.017"}], "href": "https://doi.org/10.1016/j.placenta.2009.11.017"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20036773"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20036773"}]}, {"type": "r", "ref": 35, "children": [{"type": "t", "text": "Wanruchada Katchamart, Sindhu Johnson, Hsing-Ju Lucy Lin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Predictors for remission in rheumatoid arthritis patients: A systematic review."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Arthritis Care Res (Hoboken) (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/acr.20188"}], "href": "https://doi.org/10.1002/acr.20188"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20235210"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20235210"}]}, {"type": "r", "ref": 36, "children": [{"type": "t", "text": "Jannie Gregers, Ib Jarle Christensen, Kim Dalhoff, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The association of reduced folate carrier 80G>A polymorphism to outcome in childhood acute lymphoblastic leukemia interacts with chromosome 21 copy number."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Blood (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1182/blood-2010-01-256958"}], "href": "https://doi.org/10.1182/blood-2010-01-256958"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20335220"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20335220"}]}, {"type": "r", "ref": 37, "children": [{"type": "t", "text": "S Jill James, Stepan Melnyk, Stefanie Jernigan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A functional polymorphism in the reduced folate carrier gene and DNA hypomethylation in mothers of children with autism."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Med Genet B Neuropsychiatr Genet (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/ajmg.b.31094"}], "href": "https://doi.org/10.1002/ajmg.b.31094"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20468076"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20468076"}]}, {"type": "r", "ref": 38, "children": [{"type": "t", "text": "Jayaram Vijayakrishnan, Richard S Houlston "}, {"type": "b", "children": [{"type": "t", "text": "Candidate gene association studies and risk of childhood acute lymphoblastic leukemia: a systematic review and meta-analysis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Haematologica (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3324/haematol.2010.022095"}], "href": "https://doi.org/10.3324/haematol.2010.022095"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20511665"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20511665"}]}, {"type": "r", "ref": 39, "children": [{"type": "t", "text": "Maria Ines Nunez, Carmen Behrens, Denise M Woods, et al. "}, {"type": "b", "children": [{"type": "t", "text": "High expression of folate receptor alpha in lung cancer correlates with adenocarcinoma histology and EGFR [corrected] mutation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Thorac Oncol (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/JTO.0b013e31824de09c"}], "href": "https://doi.org/10.1097/JTO.0b013e31824de09c"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22729036"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22729036"}]}, {"type": "r", "ref": 40, "children": [{"type": "t", "text": "Michelle K Y Siu, Daniel S H Kong, Hoi Yan Chan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Paradoxical impact of two folate receptors, FRα and RFC, in ovarian cancer: effect on cell proliferation, invasion and clinical outcome."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0047201"}], "href": "https://doi.org/10.1371/journal.pone.0047201"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23144806"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23144806"}]}, {"type": "r", "ref": 41, "children": [{"type": "t", "text": "Lilah Rothem, Ilan Ifergan, Yotam Kaufman, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Resistance to multiple novel antifolates is mediated via defective drug transport resulting from clustered mutations in the reduced folate carrier gene in human leukaemia cell lines."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem J (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1042/BJ20020801"}], "href": "https://doi.org/10.1042/BJ20020801"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12139489"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12139489"}]}, {"type": "r", "ref": 42, "children": [{"type": "t", "text": "Angela M Devlin, Robert Clarke, Jacqueline Birks, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Interactions among polymorphisms in folate-metabolizing genes and serum total homocysteine concentrations in a healthy elderly population."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Clin Nutr (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/ajcn.83.3.708"}], "href": "https://doi.org/10.1093/ajcn.83.3.708"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16522921"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16522921"}]}, {"type": "r", "ref": 43, "children": [{"type": "t", "text": "Lee E Moore, Núria Malats, Nathaniel Rothman, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Polymorphisms in one-carbon metabolism and trans-sulfuration pathway genes and susceptibility to bladder cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Cancer (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/ijc.22565"}], "href": "https://doi.org/10.1002/ijc.22565"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17311259"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17311259"}]}, {"type": "r", "ref": 44, "children": [{"type": "t", "text": "Jolanta Lissowska, Mia M Gaudet, Louise A Brinton, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genetic polymorphisms in the one-carbon metabolism pathway and breast cancer risk: a population-based case-control study and meta-analyses."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Cancer (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/ijc.22604"}], "href": "https://doi.org/10.1002/ijc.22604"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17311260"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17311260"}]}, {"type": "r", "ref": 45, "children": [{"type": "t", "text": "M Drozdzik, T Rudas, A Pawlik, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Reduced folate carrier-1 80G>A polymorphism affects methotrexate treatment outcome in rheumatoid arthritis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pharmacogenomics J (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/sj.tpj.6500438"}], "href": "https://doi.org/10.1038/sj.tpj.6500438"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17325736"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17325736"}]}, {"type": "r", "ref": 46, "children": [{"type": "t", "text": "B Giusti, C Saracini, P Bolli, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genetic analysis of 56 polymorphisms in 17 genes involved in methionine metabolism in patients with abdominal aortic aneurysm."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Med Genet (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1136/jmg.2008.057851"}], "href": "https://doi.org/10.1136/jmg.2008.057851"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18635682"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18635682"}]}, {"type": "r", "ref": 47, "children": [{"type": "t", "text": "Lauren DeVos, Aurelie Chanson, Zhenhua Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Associations between single nucleotide polymorphisms in folate uptake and metabolizing genes with blood folate, homocysteine, and DNA uracil concentrations."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Clin Nutr (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/ajcn/88.4.1149"}], "href": "https://doi.org/10.1093/ajcn/88.4.1149"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18842806"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18842806"}]}, {"type": "r", "ref": 48, "children": [{"type": "t", "text": "Ana Patiño-García, Marta Zalacaín, Lucía Marrodán, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Pediatr (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.jpeds.2008.11.030"}], "href": "https://doi.org/10.1016/j.jpeds.2008.11.030"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19159907"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19159907"}]}]}]}
Synonyms RFC1, FOLT, CHMD, IFC-1, IFC1, REFC
Proteins S19A1_HUMAN
NCBI Gene ID 6573
API
Download Associations
Predicted Functions View SLC19A1's ARCHS4 Predicted Functions.
Co-expressed Genes View SLC19A1's ARCHS4 Predicted Functions.
Expression in Tissues and Cell Lines View SLC19A1's ARCHS4 Predicted Functions.

Functional Associations

SLC19A1 has 10,183 functional associations with biological entities spanning 9 categories (molecular profile, organism, chemical, disease, phenotype or trait, functional term, phrase or reference, structural feature, cell line, cell type or tissue, gene, protein or microRNA, sequence feature) extracted from 131 datasets.

Click the + buttons to view associations for SLC19A1 from the datasets below.

If available, associations are ranked by standardized value

Dataset Summary
Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles tissues with high or low expression of SLC19A1 gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset.
Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles tissues with high or low expression of SLC19A1 gene relative to other tissues from the Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles dataset.
Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray tissue samples with high or low expression of SLC19A1 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset.
Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq tissue samples with high or low expression of SLC19A1 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset.
Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles tissues with high or low expression of SLC19A1 gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset.
BioGPS Cell Line Gene Expression Profiles cell lines with high or low expression of SLC19A1 gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset.
BioGPS Human Cell Type and Tissue Gene Expression Profiles cell types and tissues with high or low expression of SLC19A1 gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset.
Carcinogenome Chemical Perturbation Carcinogenicity Signatures small molecule perturbations changing expression of SLC19A1 gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset.
CCLE Cell Line Gene CNV Profiles cell lines with high or low copy number of SLC19A1 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset.
CCLE Cell Line Gene Expression Profiles cell lines with high or low expression of SLC19A1 gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset.
CCLE Cell Line Proteomics Cell lines associated with SLC19A1 protein from the CCLE Cell Line Proteomics dataset.
CellMarker Gene-Cell Type Associations cell types associated with SLC19A1 gene from the CellMarker Gene-Cell Type Associations dataset.
ChEA Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of SLC19A1 gene from the CHEA Transcription Factor Binding Site Profiles dataset.
ChEA Transcription Factor Targets transcription factors binding the promoter of SLC19A1 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset.
ChEA Transcription Factor Targets 2022 transcription factors binding the promoter of SLC19A1 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset.
ClinVar Gene-Phenotype Associations 2025 phenotypes associated with SLC19A1 gene from the curated ClinVar Gene-Phenotype Associations 2025 dataset.
CM4AI KOLF21J CRISPRi Gene Perturbation Atlas gene perturbations changing expression of SLC19A1 gene from the CM4AI KOLF21J CRISPRi Gene Perturbation Atlas dataset.
CM4AI U2OS Cell Map Protein Localization Assemblies assemblies containing SLC19A1 protein from integrated AP-MS and IF data from the CM4AI U2OS Cell Map Protein Localization Assemblies dataset.
CMAP Signatures of Differentially Expressed Genes for Small Molecules small molecule perturbations changing expression of SLC19A1 gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
COMPARTMENTS Curated Protein Localization Evidence Scores cellular components containing SLC19A1 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset.
COMPARTMENTS Curated Protein Localization Evidence Scores 2025 cellular components containing SLC19A1 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset.
COMPARTMENTS Experimental Protein Localization Evidence Scores cellular components containing SLC19A1 protein in low- or high-throughput protein localization assays from the COMPARTMENTS Experimental Protein Localization Evidence Scores dataset.
COMPARTMENTS Experimental Protein Localization Evidence Scores 2025 cellular components containing SLC19A1 protein in low- or high-throughput protein localization assays from the COMPARTMENTS Experimental Protein Localization Evidence Scores 2025 dataset.
COMPARTMENTS Text-mining Protein Localization Evidence Scores cellular components co-occuring with SLC19A1 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset.
COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 cellular components co-occuring with SLC19A1 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset.
COSMIC Cell Line Gene CNV Profiles cell lines with high or low copy number of SLC19A1 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset.
COSMIC Cell Line Gene Mutation Profiles cell lines with SLC19A1 gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset.
CTD Gene-Chemical Interactions chemicals interacting with SLC19A1 gene/protein from the curated CTD Gene-Chemical Interactions dataset.
CTD Gene-Disease Associations diseases associated with SLC19A1 gene/protein from the curated CTD Gene-Disease Associations dataset.
DeepCoverMOA Drug Mechanisms of Action small molecule perturbations with high or low expression of SLC19A1 protein relative to other small molecule perturbations from the DeepCoverMOA Drug Mechanisms of Action dataset.
DepMap CRISPR Gene Dependency cell lines with fitness changed by SLC19A1 gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset.
DGIdb Drug Targets 2026 interacting drugs for SLC19A1 protein from the DGIdb Drug Targets 2026 dataset.
DISEASES Curated Gene-Disease Association Evidence Scores 2025 diseases involving SLC19A1 gene from the DISEASES Curated Gene-Disease Association Evidence Scores 2025 dataset.
DISEASES Text-mining Gene-Disease Association Evidence Scores diseases co-occuring with SLC19A1 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset.
DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 diseases co-occuring with SLC19A1 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset.
DisGeNET Gene-Disease Associations diseases associated with SLC19A1 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset.
DisGeNET Gene-Phenotype Associations phenotypes associated with SLC19A1 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset.
DrugBank Drug Targets interacting drugs for SLC19A1 protein from the curated DrugBank Drug Targets dataset.
ENCODE Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at SLC19A1 gene from the ENCODE Histone Modification Site Profiles dataset.
ENCODE Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of SLC19A1 gene from the ENCODE Transcription Factor Binding Site Profiles dataset.
ENCODE Transcription Factor Targets transcription factors binding the promoter of SLC19A1 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset.
ESCAPE Omics Signatures of Genes and Proteins for Stem Cells PubMedIDs of publications reporting gene signatures containing SLC19A1 from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset.
GAD Gene-Disease Associations diseases associated with SLC19A1 gene in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset.
GAD High Level Gene-Disease Associations diseases associated with SLC19A1 gene in GWAS and other genetic association datasets from the GAD High Level Gene-Disease Associations dataset.
GDSC Cell Line Gene Expression Profiles cell lines with high or low expression of SLC19A1 gene relative to other cell lines from the GDSC Cell Line Gene Expression Profiles dataset.
GeneRIF Biological Term Annotations biological terms co-occuring with SLC19A1 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset.
GeneSigDB Published Gene Signatures PubMedIDs of publications reporting gene signatures containing SLC19A1 from the GeneSigDB Published Gene Signatures dataset.
GEO Signatures of Differentially Expressed Genes for Diseases disease perturbations changing expression of SLC19A1 gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset.
GEO Signatures of Differentially Expressed Genes for Gene Perturbations gene perturbations changing expression of SLC19A1 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset.
GEO Signatures of Differentially Expressed Genes for Kinase Perturbations kinase perturbations changing expression of SLC19A1 gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset.
GEO Signatures of Differentially Expressed Genes for Small Molecules small molecule perturbations changing expression of SLC19A1 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset.
GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations transcription factor perturbations changing expression of SLC19A1 gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset.
GEO Signatures of Differentially Expressed Genes for Viral Infections virus perturbations changing expression of SLC19A1 gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset.
GO Biological Process Annotations 2015 biological processes involving SLC19A1 gene from the curated GO Biological Process Annotations 2015 dataset.
GO Biological Process Annotations 2023 biological processes involving SLC19A1 gene from the curated GO Biological Process Annotations 2023 dataset.
GO Biological Process Annotations 2025 biological processes involving SLC19A1 gene from the curated GO Biological Process Annotations2025 dataset.
GO Cellular Component Annotations 2015 cellular components containing SLC19A1 protein from the curated GO Cellular Component Annotations 2015 dataset.
GO Cellular Component Annotations 2023 cellular components containing SLC19A1 protein from the curated GO Cellular Component Annotations 2023 dataset.
GO Cellular Component Annotations 2025 cellular components containing SLC19A1 protein from the curated GO Cellular Component Annotations 2025 dataset.
GO Molecular Function Annotations 2015 molecular functions performed by SLC19A1 gene from the curated GO Molecular Function Annotations 2015 dataset.
GO Molecular Function Annotations 2023 molecular functions performed by SLC19A1 gene from the curated GO Molecular Function Annotations 2023 dataset.
GO Molecular Function Annotations 2025 molecular functions performed by SLC19A1 gene from the curated GO Molecular Function Annotations 2025 dataset.
GTEx eQTL 2025 SNPs regulating expression of SLC19A1 gene from the GTEx eQTL 2025 dataset.
GTEx Tissue Gene Expression Profiles tissues with high or low expression of SLC19A1 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset.
GTEx Tissue Gene Expression Profiles 2023 tissues with high or low expression of SLC19A1 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset.
GTEx Tissue Sample Gene Expression Profiles tissue samples with high or low expression of SLC19A1 gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset.
GTEx Tissue-Specific Aging Signatures tissue samples with high or low expression of SLC19A1 gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset.
Guide to Pharmacology Chemical Ligands of Receptors ligands (chemical) binding SLC19A1 receptor from the curated Guide to Pharmacology Chemical Ligands of Receptors dataset.
GWAS Catalog SNP-Phenotype Associations 2025 phenotypes associated with SLC19A1 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset.
GWASdb SNP-Disease Associations diseases associated with SLC19A1 gene in GWAS and other genetic association datasets from the GWASdb SNP-Disease Associations dataset.
GWASdb SNP-Phenotype Associations phenotypes associated with SLC19A1 gene in GWAS datasets from the GWASdb SNP-Phenotype Associations dataset.
Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles cell lines with high or low expression of SLC19A1 gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset.
HMDB Metabolites of Enzymes interacting metabolites for SLC19A1 protein from the curated HMDB Metabolites of Enzymes dataset.
HPA Cell Line Gene Expression Profiles cell lines with high or low expression of SLC19A1 gene relative to other cell lines from the HPA Cell Line Gene Expression Profiles dataset.
HPA Tissue Gene Expression Profiles tissues with high or low expression of SLC19A1 gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset.
HPA Tissue Protein Expression Profiles tissues with high or low expression of SLC19A1 protein relative to other tissues from the HPA Tissue Protein Expression Profiles dataset.
HPA Tissue Sample Gene Expression Profiles tissue samples with high or low expression of SLC19A1 gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset.
HuBMAP ASCT+B Annotations cell types associated with SLC19A1 gene from the HuBMAP ASCT+B dataset.
HuBMAP ASCT+B Augmented with RNA-seq Coexpression cell types associated with SLC19A1 gene from the HuBMAP ASCT+B Augmented with RNA-seq Coexpression dataset.
HuGE Navigator Gene-Phenotype Associations phenotypes associated with SLC19A1 gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset.
InterPro Predicted Protein Domain Annotations protein domains predicted for SLC19A1 protein from the InterPro Predicted Protein Domain Annotations dataset.
JASPAR Predicted Human Transcription Factor Targets 2025 transcription factors regulating expression of SLC19A1 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset.
JASPAR Predicted Mouse Transcription Factor Targets 2025 transcription factors regulating expression of SLC19A1 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset.
JASPAR Predicted Transcription Factor Targets transcription factors regulating expression of SLC19A1 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset.
KEGG Pathways 2026 pathways involving SLC19A1 protein from the KEGG Pathways 2026 dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles cell lines with high or low copy number of SLC19A1 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles cell lines with high or low expression of SLC19A1 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles cell lines with SLC19A1 gene mutations from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles dataset.
KnockTF Gene Expression Profiles with Transcription Factor Perturbations transcription factor perturbations changing expression of SLC19A1 gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset.
LINCS L1000 CMAP Chemical Perturbation Consensus Signatures small molecule perturbations changing expression of SLC19A1 gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset.
LINCS L1000 CMAP CRISPR Knockout Consensus Signatures gene perturbations changing expression of SLC19A1 gene from the LINCS L1000 CMAP CRISPR Knockout Consensus Signatures dataset.
LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules small molecule perturbations changing expression of SLC19A1 gene from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
LOCATE Curated Protein Localization Annotations cellular components containing SLC19A1 protein in low- or high-throughput protein localization assays from the LOCATE Curated Protein Localization Annotations dataset.
LOCATE Predicted Protein Localization Annotations cellular components predicted to contain SLC19A1 protein from the LOCATE Predicted Protein Localization Annotations dataset.
MGI Mouse Phenotype Associations 2023 phenotypes of transgenic mice caused by SLC19A1 gene mutations from the MGI Mouse Phenotype Associations 2023 dataset.
MiRTarBase microRNA Targets microRNAs targeting SLC19A1 gene in low- or high-throughput microRNA targeting studies from the MiRTarBase microRNA Targets dataset.
MotifMap Predicted Transcription Factor Targets transcription factors regulating expression of SLC19A1 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset.
MoTrPAC Rat Endurance Exercise Training tissue samples with high or low expression of SLC19A1 gene relative to other tissue samples from the MoTrPAC Rat Endurance Exercise Training dataset.
MPO Gene-Phenotype Associations phenotypes of transgenic mice caused by SLC19A1 gene mutations from the MPO Gene-Phenotype Associations dataset.
MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations gene perturbations changing expression of SLC19A1 gene from the MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations dataset.
NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles drug perturbations changing expression of SLC19A1 gene from the NIBR DRUG-seq U2OS MoA Box dataset.
NURSA Protein Complexes protein complexs containing SLC19A1 protein recovered by IP-MS from the NURSA Protein Complexes dataset.
Pathway Commons Protein-Protein Interactions interacting proteins for SLC19A1 from the Pathway Commons Protein-Protein Interactions dataset.
PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations gene perturbations changing expression of SLC19A1 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset.
PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations gene perturbations changing expression of SLC19A1 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset.
PFOCR Pathway Figure Associations 2023 pathways involving SLC19A1 protein from the PFOCR Pathway Figure Associations 2023 dataset.
PFOCR Pathway Figure Associations 2024 pathways involving SLC19A1 protein from the Wikipathways PFOCR 2024 dataset.
Reactome Pathways 2014 pathways involving SLC19A1 protein from the Reactome Pathways dataset.
Reactome Pathways 2024 pathways involving SLC19A1 protein from the Reactome Pathways 2024 dataset.
Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures gene perturbations changing expression of SLC19A1 gene from the Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures dataset.
Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures gene perturbations changing expression of SLC19A1 gene from the Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures dataset.
Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles cell types and tissues with high or low DNA methylation of SLC19A1 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles dataset.
Roadmap Epigenomics Cell and Tissue Gene Expression Profiles cell types and tissues with high or low expression of SLC19A1 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue Gene Expression Profiles dataset.
Roadmap Epigenomics Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at SLC19A1 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset.
Rummagene Transcription Factor Associations 2026 transcription factors regulating expression of SLC19A1 gene from the Rummagene Transcription Factor Associations 2026 dataset.
RummaGEO Drug Perturbation Signatures drug perturbations changing expression of SLC19A1 gene from the RummaGEO Drug Perturbation Signatures dataset.
RummaGEO Gene Perturbation Signatures gene perturbations changing expression of SLC19A1 gene from the RummaGEO Gene Perturbation Signatures dataset.
Sanger Dependency Map Cancer Cell Line Proteomics cell lines associated with SLC19A1 protein from the Sanger Dependency Map Cancer Cell Line Proteomics dataset.
Sci-Plex Drug Perturbation Signatures drug perturbations changing expression of SLC19A1 gene from the Sci-Plex Drug Perturbation Signatures dataset.
Tabula Sapiens Gene-Cell Associations cell types with high or low expression of SLC19A1 gene relative to other cell types from the Tabula Sapiens Gene-Cell Associations dataset.
Tahoe Therapeutics Tahoe 100M Perturbation Atlas drug perturbations changing expression of SLC19A1 gene from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
TargetScan Predicted Nonconserved microRNA Targets microRNAs regulating expression of SLC19A1 gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset.
TCGA Signatures of Differentially Expressed Genes for Tumors tissue samples with high or low expression of SLC19A1 gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.
TISSUES Curated Tissue Protein Expression Evidence Scores tissues with high expression of SLC19A1 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores dataset.
TISSUES Curated Tissue Protein Expression Evidence Scores 2025 tissues with high expression of SLC19A1 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset.
TISSUES Experimental Tissue Protein Expression Evidence Scores tissues with high expression of SLC19A1 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores dataset.
TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 tissues with high expression of SLC19A1 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset.
TISSUES Text-mining Tissue Protein Expression Evidence Scores tissues co-occuring with SLC19A1 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset.
TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 tissues co-occuring with SLC19A1 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset.
WikiPathways Pathways 2014 pathways involving SLC19A1 protein from the Wikipathways Pathways 2014 dataset.
WikiPathways Pathways 2024 pathways involving SLC19A1 protein from the WikiPathways Pathways 2024 dataset.